Multicenter Investigation of Trabecular Micro-Bypass Stents vs. Laser Trabeculoplasty

Glaukos Corporation91 enrolled

Overview

To evaluate the safety and effectiveness of Trabecular Micro-Bypass stents (two stents per study eye) vs. laser trabeculoplasty, in subjects with open angle glaucoma

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Primary Open-Angle Glaucoma

Interventions

StentsDEVICE

Two Trabecular meshwork Micro-Bypass stents into the study eye

LaserPROCEDURE

Laser Trabeculoplasty

Laser TrabeculoplastyDEVICE

Eligibility

Sex: ALLMin age: 35 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Open angle Glaucoma Exclusion Criteria: * Active corneal inflammation or edema * Choroidal detachment, effusion, choroiditis

Locations (9)

Unnamed facility

Glendale, Arizona, United States

Unnamed facility

Fayetteville, Arkansas, United States

Unnamed facility

Hemet, California, United States

Unnamed facility

Cape Coral, Florida, United States

Outcomes

Primary Outcomes

IOP reduction

Time frame: up to 24 months

Secondary Outcomes

% IOP reduction

Time frame: up to 24 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.